IL34 and colorectal carcinoma: In this context, however, further work is needed to confirm the in vitro data generated using cells isolated from human CRC samples in pre-clinical models of CRC and ascertain whether IL-34 blockers can enhance the properties of other anti-tumoural drugs, including chemotherapeutics and biologics.